glucagon has been researched along with Injury, Myocardial Reperfusion in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, LP; Sha, WW; Wang, JC; Wang, SX; Wang, WL; Xie, Y; Yu, DM; Zhou, X | 1 |
| Genis, A; Huisamen, B; Lochner, A; Marais, E | 1 |
| Doverspike, A; Elahi, D; Hentosz, T; Nikolaidis, LA; Shannon, RP; Shen, YT; Zourelias, L | 1 |
| Bose, AK; Brand, CL; Carr, RD; Mocanu, MM; Yellon, DM | 1 |
| Bose, AK; Carr, RD; Mocanu, MM; Yellon, DM | 1 |
5 other study(ies) available for glucagon and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
[Effect of glucagon-like peptide-1 on hypoxia-reoxygenation induced injury in neonatal rat cardiomyocytes].
Topics: Animals; Animals, Newborn; Apoptosis; Caspase 3; Cell Hypoxia; Cells, Cultured; Glucagon; Glucagon-Like Peptide 1; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Rats, Wistar | 2010 |
Pre-treatment with a DPP-4 inhibitor is infarct sparing in hearts from obese, pre-diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Cardiotonic Agents; Dipeptidyl-Peptidase IV Inhibitors; Glucagon; Glucagon-Like Peptide 1; Insulin; Insulin Resistance; Male; Myocardial Reperfusion Injury; Myocytes, Cardiac; Obesity; Pancreas; Phosphotransferases; Prediabetic State; Rats; Rats, Wistar | 2011 |
Glucagon-like peptide-1 limits myocardial stunning following brief coronary occlusion and reperfusion in conscious canines.
Topics: Animals; Coronary Circulation; Disease Models, Animal; Dogs; Glucagon; Glucagon-Like Peptide 1; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardial Stunning; Peptide Fragments; Protein Precursors | 2005 |
Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury.
Topics: Animals; Blood Pressure; Butadienes; Chromones; Disease Models, Animal; Enzyme Inhibitors; Glucagon; Glucagon-Like Peptide 1; Heart Rate; In Vitro Techniques; Insulin; Insulin Secretion; Male; MAP Kinase Signaling System; Morpholines; Myocardial Infarction; Myocardial Reperfusion Injury; Nitriles; Peptide Fragments; Phosphoinositide-3 Kinase Inhibitors; Protein Precursors; Rats; Rats, Sprague-Dawley; Time Factors | 2005 |
Glucagon like peptide-1 is protective against myocardial ischemia/reperfusion injury when given either as a preconditioning mimetic or at reperfusion in an isolated rat heart model.
Topics: Animals; Cardiotonic Agents; Glucagon; Glucagon-Like Peptide 1; Humans; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Myocardial Reperfusion; Myocardial Reperfusion Injury; Peptide Fragments; Protein Precursors; Rats; Rats, Sprague-Dawley; Time Factors | 2005 |